Risk-Based Monitoring
- $299
Identifying Workforce Gaps Post Risk-Based Monitoring (RBM): It’s Time to “DIG” in!Sandra “SAM” SatherOctober 1, 2019 | 1 PM EDT - $279
New FDA Draft Guidance – A Risk-Based Approach to Monitoring of Clinical InvestigationsSandra “SAM” SatherOn-Demand - $279
- $299
- $279
FINAL Risk-based Monitoring Guidance: Updates, Impact & Analysis on Clinical Monitoring SystemsSandra “SAM” SatherOn-demand - $279
- $1199
- $279 Investigator Oversight Plans: Essentials for Inspection Readiness Post ICH GCP E6 (R2) AddendumSandra “SAM” SatherOn-Demand
